Oxford Nanopore Technologies recently declared raising £25 million through shares. The capital investment will enable development, third party technology validation and manufacturing facilities for technology to be used in molecular analysis applications such as DNA sequencing and analysis of protein.
The company will also boost the ongoing projects and joint ventures to develop solid-state nanopores.
The shares have been purchased by institutions and individuals originating from the US and UK such as Lansdowne Partners, IP Group, Invesco Perpetual, Redmile Group and Illumina. The investment does not come from the general public.
The, GridION technology comprises a scalable modular tool that holds consumable cartridge. It can be used to analyze multiple types of molecules such as DNA and proteins by altering the nanopore that the cartridge contains.
The technology incorporates methods from areas such as nanopore science, electronics, high-speed data processing, fluidics and software development. The new investment will also help the company to support educational research programmes.